While Congressional leaders play chicken with the debt ceiling this week, antipathy toward hospitals is mounting. To be fair, hospitals are not alone: drug companies and PBMs share the distinction…
The national spotlight this week will be on the debt ceiling stand-off in Congress, the end of Title 42 that enables immigrants’ legal access to the U.S., the April CPI…
Tit for Tat battles in healthcare are nothing new. Last week, they were on full display. Health insurers and drug manufacturers squared off in national ad campaigns accusing the other…
Last week, 35,000 gathered in Chicago to hear about the future of health information technologies at the HIMSS Global Health Conference & Exhibition where generative AI, smart devices and cybersecurity…
In recent months, compensation for hospital CEOs has received heightened attention among regulators, policymakers, academic researchers and in media: On August 25, 2022, the SEC adopted final rules requiring public…
On Monday, April 3 in Chicago, 11 C suite executives from some of the most prestigious not-for-profit health systems in the country convened to discuss their future. The group included…
At a meeting with hospital system CEOs last Wednesday, one asked: “has healthcare reached the tipping point?” I replied ‘not yet but it’s getting close.’ I iterated factors that make…
Large, not-for-profit hospitals/health systems are getting a disproportionate share of unflattering attention these days. Last week was no exception: Here’s a smattering of their coverage: Approximate Savings from Lowering Indiana…
Thursday marks the 13th anniversary of the signing of the Affordable Care Act– perhaps the most consequential healthcare legislation since LBJ’s passage of the Medicare Act in 1965. Except in…
March 12, 2023 Last Thursday, the Biden administration released its proposed FY24 federal budget which is certain to spark political posturing by partisans on all sides and long-term speculation by…
Stay informed with Paul’s unique perspective on healthcare happenings, from policies and politics to innovations and investments. Subscribe today to the Keckley Report and be the first to receive Paul’s weekly insights and special reports.
© 2025 Paul Keckley.
